Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II, Open Label Study to Determine Safety of Trifluoperazine (TFP) in Adults With Red Blood Cell Transfusion-Dependent Diamond Blackfan Anemia

NCT03966053 is registered in ClinicalTrials.gov with Adrianna Vlachos, MD as lead sponsor.

NCT NCT03966053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03966053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II, Open Label Study to Determine Safety of Trifluoperazine (TFP) in Adults With Red Blood Cell Transfusion-Dependent Diamond Blackfan Anemia
Lead sponsor
Adrianna Vlachos, MD
Phase
Phase 1/2
Overall status
Terminated
Start date
September 13, 2019
Completion date
October 13, 2021
Enrollment
2 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diamond blackfan anemia, pure red cell aplasia